U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 57

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr2:48033619-48033620
GRCh38:
Chr2:47806480-47806481
MSH6Q1280fs, Q1150fs, Q978fsEndometrial carcinoma, Mismatch repair cancer syndrome 3, Lynch syndrome 5,
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome
Pathogenic/Likely pathogenic
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
2.
GRCh37:
Chr2:48027806
GRCh38:
Chr2:47800667
MSH6T593R, T765R, T895REndometrial carcinoma, Lynch syndrome 5, Mismatch repair cancer syndrome 3,
Hereditary nonpolyposis colorectal neoplasms
Uncertain significance
(Oct 19, 2021)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr2:48033943-48033944
GRCh38:
Chr2:47806804-47806805
MSH6Endometrial carcinoma, Mismatch repair cancer syndrome 3, Lynch syndrome 5,
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome
Uncertain significance
(Aug 26, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr2:48023164
GRCh38:
Chr2:47796025
MSH6D197HEndometrial carcinoma, Lynch syndrome 5, Mismatch repair cancer syndrome 3,
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
5.
GRCh37:
Chr2:48032740
GRCh38:
Chr2:47805601
MSH6Hereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 3, Endometrial carcinoma,
Lynch syndrome 5
Likely benign
(Mar 31, 2022)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr2:48030637
GRCh38:
Chr2:47803498
MSH6D1084G, D782G, D954GHereditary cancer-predisposing syndrome, MSH6-related condition, Lynch syndrome 5,
Mismatch repair cancer syndrome 3, Endometrial carcinoma, Hereditary nonpolyposis colorectal neoplasms
Uncertain significance
(Sep 8, 2023)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr2:48030727
GRCh38:
Chr2:47803588
MSH6L1114Q, L812Q, L984QHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 3,
Lynch syndrome 5, Endometrial carcinoma, not provided
Uncertain significance
(Mar 14, 2023)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr2:48010592
GRCh38:
Chr2:47783453
MSH6G74*Hereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 3, Lynch syndrome 5,
Endometrial carcinoma, Hereditary nonpolyposis colorectal neoplasms
Pathogenic
(Oct 25, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr2:48028136
GRCh38:
Chr2:47800997
MSH6R1005L, R875L, R703LHereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 3, Endometrial carcinoma,
Lynch syndrome 5, Hereditary nonpolyposis colorectal neoplasms
Uncertain significance
(Jul 29, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr2:48027863
GRCh38:
Chr2:47800724
MSH6T914I, T612I, T784IMismatch repair cancer syndrome 3, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Aug 10, 2022)
criteria provided, conflicting interpretations
11.
GRCh37:
Chr2:48018167
GRCh38:
Chr2:47791028
MSH6R121HLynch syndrome 5, Endometrial carcinoma, Mismatch repair cancer syndrome 3,
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms, not provided
Conflicting interpretations of pathogenicity
(Jun 13, 2023)
criteria provided, conflicting interpretations
12.
GRCh37:
Chr2:48033435
GRCh38:
Chr2:47806296
MSH6T1247A, T945A, T1117ALynch syndrome 5, Endometrial carcinoma, Mismatch repair cancer syndrome 3,
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms, not provided
Uncertain significance
(Dec 9, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr2:48032807
GRCh38:
Chr2:47805668
MSH6H1203N, H1073N, H901NHereditary nonpolyposis colorectal neoplasms, not provided, Hereditary cancer-predisposing syndrome,
Mismatch repair cancer syndrome 3, Endometrial carcinoma, Lynch syndrome 5
Conflicting interpretations of pathogenicity
(Mar 2, 2023)
criteria provided, conflicting interpretations
14.
GRCh37:
Chr2:48032786
GRCh38:
Chr2:47805647
MSH6E1196Q, E1066Q, E894QHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided,
Mismatch repair cancer syndrome 3, Endometrial carcinoma, Lynch syndrome 5
Conflicting interpretations of pathogenicity
(Apr 26, 2023)
criteria provided, conflicting interpretations
15.
GRCh37:
Chr2:48026660
GRCh38:
Chr2:47799521
MSH6I513T, I211T, I383THereditary cancer-predisposing syndrome, not provided, Hereditary nonpolyposis colorectal neoplasms,
Mismatch repair cancer syndrome 3, Endometrial carcinoma, Lynch syndrome 5
Uncertain significance
(Oct 20, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr2:48030583-48030597
GRCh38:
Chr2:47803444-47803458
MSH6Hereditary nonpolyposis colorectal neoplasms, Endometrial carcinoma, Mismatch repair cancer syndrome 3,
Lynch syndrome 5
Uncertain significance
(Dec 10, 2021)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr2:48033511
GRCh38:
Chr2:47806372
MSH6Hereditary nonpolyposis colorectal neoplasms, Breast and/or ovarian cancer, not specified,
Lynch syndrome 5, Endometrial carcinoma, Mismatch repair cancer syndrome 3,
Hereditary cancer-predisposing syndrome
Benign/Likely benign
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr2:48028192
GRCh38:
Chr2:47801053
MSH6R1024W, R894W, R722WHereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 3, Lynch syndrome 5,
Endometrial carcinoma, Hereditary nonpolyposis colorectal neoplasms, not provided
Conflicting interpretations of pathogenicity
(Apr 18, 2023)
criteria provided, conflicting interpretations
19.
GRCh37:
Chr2:48026471-48026472
GRCh38:
Chr2:47799332-47799333
MSH6F321fs, F451fs, F149fsHereditary nonpolyposis colorectal neoplasms, Lynch syndrome 5, Mismatch repair cancer syndrome 3,
Lynch syndrome 5, Endometrial carcinoma, Hereditary cancer-predisposing syndrome
Pathogenic/Likely pathogenic
(Mar 28, 2023)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr2:48027220
GRCh38:
Chr2:47800081
MSH6L700I, L570I, L398IHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Endometrial carcinoma,
Mismatch repair cancer syndrome 3, Lynch syndrome 5, Lynch syndrome
Uncertain significance
(Oct 24, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr2:48027790
GRCh38:
Chr2:47800651
MSH6V890F, V588F, V760FEndometrial carcinoma, Mismatch repair cancer syndrome 3, Lynch syndrome 5,
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not specified
Conflicting interpretations of pathogenicity
(May 31, 2023)
criteria provided, conflicting interpretations
22.
GRCh37:
Chr2:48033438
GRCh38:
Chr2:47806299
MSH6H1248Y, H946Y, H1118YEndometrial carcinoma, Mismatch repair cancer syndrome 3, Lynch syndrome 5,
Hereditary nonpolyposis colorectal neoplasms, not provided, Hereditary cancer-predisposing syndrome
Uncertain significance
(Nov 23, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr2:48033944
GRCh38:
Chr2:47806805
MSH6S1343*, S1041*, S1213*Lynch syndrome 5, Endometrial carcinoma, Mismatch repair cancer syndrome 3,
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms
Uncertain significance
(Oct 23, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr2:48033988
GRCh38:
Chr2:47806849
MSH6K1358E, K1228E, K1056EEndometrial carcinoma, Lynch syndrome 5, Mismatch repair cancer syndrome 3,
Lynch syndrome 1
Uncertain significance
(Oct 31, 2021)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr2:48030614
GRCh38:
Chr2:47803475
MSH6Hereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 3, Endometrial carcinoma,
Lynch syndrome 5
Likely benign
(Apr 1, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr2:48010382
GRCh38:
Chr2:47783243
MSH6Q4*Endometrial carcinoma, Mismatch repair cancer syndrome 3, Lynch syndrome 5,
Breast and/or ovarian cancer, MSH6-related condition, Hereditary cancer-predisposing syndrome,
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome, not provided,
Lynch syndrome 5
Pathogenic/Likely pathogenic
(Mar 28, 2023)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr2:48033802-48033805
GRCh38:
Chr2:47806652-47806653
MSH6Endometrial carcinoma, Mismatch repair cancer syndrome 3, Lynch syndrome 5,
Hereditary nonpolyposis colorectal neoplasms, not specified, Hereditary cancer-predisposing syndrome,
not provided, Lynch syndrome 5
Benign/Likely benign
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr2:48026312
GRCh38:
Chr2:47799173
MSH6Y397C, Y267C, Y95CHereditary nonpolyposis colorectal neoplasms, Mismatch repair cancer syndrome 3, Lynch syndrome 5,
Endometrial carcinoma, Hereditary cancer-predisposing syndrome, not specified,
Lynch syndrome, Hereditary breast ovarian cancer syndrome, Lynch syndrome 5,
not provided
Conflicting interpretations of pathogenicity
(Sep 18, 2023)
criteria provided, conflicting interpretations
29.
GRCh37:
Chr2:48025953
GRCh38:
Chr2:47798814
MSH6E277D, E147DEndometrial carcinoma, Lynch syndrome 5, Mismatch repair cancer syndrome 3,
Hereditary nonpolyposis colorectal neoplasms, MSH6-related condition, Hereditary cancer-predisposing syndrome,
not provided, not specified, Lynch syndrome 5
Conflicting interpretations of pathogenicity
(Sep 6, 2023)
criteria provided, conflicting interpretations
30.
GRCh37:
Chr2:48027775
GRCh38:
Chr2:47800636
MSH6K885*, K755*, K583*Hereditary nonpolyposis colorectal neoplasms, Mismatch repair cancer syndrome 3, Hereditary cancer-predisposing syndrome,
not provided
Pathogenic
(Aug 9, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr2:48033991-48033992
GRCh38:
Chr2:47806852-47806853
MSH6MSH6-related condition, Endometrial carcinoma, Lynch syndrome 5,
Mismatch repair cancer syndrome 3, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome,
not specified, not provided, Lynch syndrome 5
Uncertain significance
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr2:48028314
GRCh38:
Chr2:47801175
MSH6Endometrial carcinoma, Mismatch repair cancer syndrome 3, Lynch syndrome 5,
Hereditary nonpolyposis colorectal neoplasms, Breast and/or ovarian cancer, Hereditary cancer-predisposing syndrome,
not specified
Benign/Likely benign
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr2:48025928
GRCh38:
Chr2:47798789
MSH6T269S, T139SHereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not specified,
not provided, Endometrial carcinoma, Lynch syndrome 5,
Mismatch repair cancer syndrome 3
Conflicting interpretations of pathogenicity
(Aug 15, 2023)
criteria provided, conflicting interpretations
34.
GRCh37:
Chr2:48025782
GRCh38:
Chr2:47798643
MSH6E220D, E90DLynch syndromeLikely benign
(Sep 5, 2013)
reviewed by expert panel
35.
GRCh37:
Chr2:48025764
GRCh38:
Chr2:47798625
MSH6Y214*, Y84*Lynch syndromePathogenic
(Sep 5, 2013)
reviewed by expert panel
36.
GRCh37:
Chr2:48033792-48033795
GRCh38:
Chr2:47806653-47806656
MSH6Lynch syndromeLikely benign
(Jun 21, 2019)
reviewed by expert panel
37.
GRCh37:
Chr2:48033727-48033728
GRCh38:
Chr2:47806588-47806589
MSH6Lynch syndromePathogenic
(Sep 5, 2013)
reviewed by expert panel
38.
GRCh37:
Chr2:48032740-48032741
GRCh38:
Chr2:47805601-47805602
MSH6Lynch syndromeBenign
(Sep 5, 2013)
reviewed by expert panel
39.
GRCh37:
Chr2:48032048
GRCh38:
Chr2:47804909
MSH6Lynch syndromeLikely pathogenic
(Jun 21, 2019)
reviewed by expert panel
40.
GRCh37:
Chr2:48032033
GRCh38:
Chr2:47804894
MSH6Lynch syndromeBenign
(Sep 5, 2013)
reviewed by expert panel
41.
GRCh37:
Chr2:48030772-48030774
GRCh38:
Chr2:47803633-47803635
MSH6Mismatch repair cancer syndrome 3Pathogenic
(Jan 1, 2004)
no assertion criteria provided
42.
GRCh37:
Chr2:48030639-48030640
GRCh38:
Chr2:47803500-47803501
MSH6F1088fs, F786fs, F958fsLynch syndromePathogenic
(Sep 5, 2013)
reviewed by expert panel
43.
GRCh37:
Chr2:48030640
GRCh38:
Chr2:47803501
MSH6F958fs, F786fsLynch syndromePathogenic
(Sep 5, 2013)
reviewed by expert panel
44.
GRCh37:
Chr2:48028225
GRCh38:
Chr2:47801086
MSH6R1035*, R733*, R905*Lynch syndromePathogenic
(Sep 5, 2013)
reviewed by expert panel
45.
GRCh37:
Chr2:48028142
GRCh38:
Chr2:47801003
MSH6W1007*, W705*, W877*Lynch syndromePathogenic
(Sep 5, 2013)
reviewed by expert panel
46.
GRCh37:
Chr2:48027853
GRCh38:
Chr2:47800714
MSH6R911*, R609*, R781*Lynch syndromePathogenic
(Sep 5, 2013)
reviewed by expert panel
47.
GRCh37:
Chr2:48027269-48027272
GRCh38:
Chr2:47800130-47800133
MSH6V415fs, V587fsLynch syndromePathogenic
(Sep 5, 2013)
reviewed by expert panel
48.
GRCh37:
Chr2:48027227
GRCh38:
Chr2:47800088
MSH6S702*, S400*, S572*Lynch syndromePathogenic
(Sep 5, 2013)
reviewed by expert panel
49.
GRCh37:
Chr2:48026861
GRCh38:
Chr2:47799722
MSH6S580L, S278L, S450LMismatch repair cancer syndrome 3, Endometrial carcinoma, Lynch syndrome 5,
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided,
not specified
Conflicting interpretations of pathogenicity
(Mar 21, 2023)
criteria provided, conflicting interpretations
50.
GRCh37:
Chr2:48026630
GRCh38:
Chr2:47799491
MSH6S201C, S373CLynch syndromeLikely benign
(Sep 5, 2013)
reviewed by expert panel
51.
GRCh37:
Chr2:48033780
GRCh38:
Chr2:47806641
MSH6R1331*, R1029*, R1201*Lynch syndromePathogenic
(Sep 5, 2013)
reviewed by expert panel
52.
GRCh37:
Chr2:48030838
GRCh38:
Chr2:47803699
MSH6Lynch syndromeBenign
(Sep 5, 2013)
reviewed by expert panel
53.
GRCh37:
Chr2:48026648
GRCh38:
Chr2:47799509
MSH6V509A, V207A, V379ALynch syndromeLikely benign
(Sep 5, 2013)
reviewed by expert panel
54.
GRCh37:
Chr2:48025764
GRCh38:
Chr2:47798625
MSH6Lynch syndromeBenign
(Sep 5, 2013)
reviewed by expert panel
55.
GRCh37:
Chr2:48023115
GRCh38:
Chr2:47795976
MSH6Lynch syndromeBenign
(Sep 5, 2013)
reviewed by expert panel
56.
GRCh37:
Chr2:48025772-48025773
GRCh38:
Chr2:47798633-47798634
MSH6K88*, K218*Lynch syndromePathogenic
(Sep 5, 2013)
reviewed by expert panel
57.
GRCh37:
Chr2:48027755
GRCh38:
Chr2:47800616
MSH6V878A, V576A, V748ALynch syndromeBenign
(Sep 5, 2013)
reviewed by expert panel
Format
Items per page
Sort by
Choose Destination